Hydroxychloroquine sulfate
Plaquenil (hydroxychloroquine sulfate) is a prescription tablet used to treat malaria and certain autoimmune conditions like rheumatoid arthritis and lupus. Each tablet contains 200 mg of the active ingredient and is taken orally. Manufactured by Advanz Pharma, it's available in various bottle sizes. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Plaquenil (hydroxychloroquine sulfate) is a prescription tablet used to treat malaria and certain autoimmune conditions like rheumatoid arthritis and lupus. Each tablet contains 200 mg of the active ingredient and is taken orally. Manufactured by Advanz Pharma, it's available in various bottle sizes. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Hydroxychloroquine sulfate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Hydroxychloroquine sulfate — ANDA 201691 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201691"
}
]
|
| identifier | ANDA201691 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"drug-safety",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Hydroxychloroquine sulfate |
